Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'24
  • Budget'26 Budget'25 Budget'24
    • Home
    • News
    NSE IPO GMP Surges to Rs 285 Ahead of September 25 Listing Target

    NSE IPO GMP Surges to Rs 285 Ahead of September 25 Listing Target


    Finance Outlook India Team | Monday, 07 September 2026

    The highly anticipated NSE IPO is generating strong buzz in the grey market ahead of its expected stock-market debut later this month. According to IPO Watch, the NSE IPO GMP - grey market premium - stood at Rs 285 on Monday, up Rs 85 from Rs 200 a day earlier.

    Key Highlights

    • NSE IPO GMP surged to Rs 285, with the exchange targeting a Rs 30,000 crore issue around September 25.
    • NSE expanded its permitted-to-trade list by 250 securities, with 106 seeing a four-fold turnover jump.

    The NSE IPO is likely to hit Dalal Street in the fourth week of September, with the exchange targeting a listing around September 25, according to reports. The exchange is expected to announce the price band next week, while the IPO could open for subscription around September 15.

    NSE Targets Rs 30,000 Crore in India's Potentially Largest-Ever IPO

    NSE is reportedly looking to raise around Rs 30,000 crore at an estimated price band of Rs 1,800-1,900 per share, implying a valuation of about Rs 5 lakh crore. If completed as planned, the issue could become India's largest-ever IPO. The shares are expected to be listed on the BSE.

    At the current GMP, investors could potentially see a listing premium of around 15% if the shares are priced near the upper end of the expected price band. However, grey market premiums remain unofficial and can change sharply before listing.

    The Securities and Exchange Board of India (SEBI) gave its approval for the proposed IPO on September 4, clearing a key regulatory hurdle nearly a decade after NSE's earlier listing plans were put on hold. NSE had filed its draft red herring prospectus (DRHP) with SEBI in June and received the regulator's final observations on September 4. The exchange has yet to formally announce the IPO size, price band, subscription dates and other issue details.

    Also Read: NSE Files DRHP for Rs 30,000 Crore IPO After Nearly a Decade

    IPO Structure: Entirely an Offer for Sale

    The proposed IPO will be entirely an offer for sale (OFS), with existing shareholders offering up to 14.89 crore equity shares, representing nearly 6% of NSE's equity, according to the DRHP.

    State Bank of India (SBI) is expected to be the largest selling shareholder, offering up to 2.48 crore shares. Mauritius-based MS Strategic plans to sell around 1.6 crore shares, while Canada Pension Plan Investment Board (CPPIB) will offload nearly 1.19 crore shares. Aranda Investments, Bank of Baroda and Stock Holding Corporation of India are also expected to participate in the OFS, while LIC, one of NSE's largest shareholders, has opted not to sell shares in the IPO.

    According to the DRHP, 50% of the net offer is reserved for qualified institutional buyers (QIBs), 15% for non-institutional investors (NIIs) and 35% for retail investors. Up to 5% of NSE's post-offer paid-up equity share capital has also been reserved for eligible employees.

    NSE Expands 'Permitted to Trade' Universe Ahead of Listing

    Separately, NSE has significantly expanded its "permitted to trade" (PTT) universe this year, adding 250 securities to a segment that had seen little activity in recent years. The expansion comes as NSE moves closer to its long-awaited listing and considers whether its own shares could eventually trade on its own platform.

    NSE added 106 securities with effect from April 20, followed by another 144 from August 17 - marking its first such addition since 2022. By comparison, BSE currently has 30 companies under its own permitted-to-trade category.

    The first batch of newly admitted securities has already seen a sharp increase in trading activity, with average daily turnover rising from about Rs 92 crore on the BSE to around Rs 400 crore across the NSE and BSE combined, after the securities became available for trading on both exchanges. Notably, 106 of the first 250 securities admitted saw a four-fold jump in turnover following their NSE admission.

    Strong Investor Interest Expected

    The NSE IPO is expected to attract significant investor interest given its dominant position in India's equity and derivatives markets, and the long-awaited opportunity for investors to finally own shares in the exchange itself.



    Read More:

    India's Startup Funding Surged 39% to $303.7 Mn in the Latest Week

    India Finance News Today: Stocks, IPOs and Corporate Updates

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25